Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:22 PM
Ignite Modification Date:
2025-12-24 @ 2:22 PM
NCT ID:
NCT02856295
Eligibility Criteria:
Inclusion Criteria:
* postpartum women supposed to receive LMWH according to obstetric indications
Exclusion Criteria:
* known allergy to clexane
* active bleeding postpartum
* thrombocytopenia \< 75000
* recent cerebrovascular accident / transient ischemic attack (\<4 weeks)
* glomerular filtration rate) \< 30 ml/min)
* active liver disease
* malignant hypertension (systolic \> 200 mmHg, diastolic\> 120 mmHg)
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT02856295
Study Brief:
Protocol Section:
NCT02856295